Background & Aims: Spontaneous portosystemic shunts (SPSSs) have been associated with hepatic encephalopathy (HE). Little is known about their prevalence among patients with cirrhosis or clinical effects. We investigated the prevalence and characteristics of SPSSs in patients with cirrhosis and their outcomes.
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INTRODUCTION
Portal hypertension is the main consequence of cirrhosis and is responsible for the majority of severe complications, such as ascites, variceal haemorrhage and hepatic encephalopathy (HE) 1, 2 . These events entail a detriment in quality of life and are associated with high mortality 3 . Furthermore, clinical decompensations often require hospital admissions and close follow-up, implying substantial costs for the health-care system 4 .
One of the consequences of portal hypertension is the formation of portosystemic collateral vessels, commonly defined as "spontaneous portosystemic shunts" (SPSS), as an attempt to decompress the portal venous system 1 . However, SPSS represent an insufficient compensatory mechanism, not allowing for an adequate reduction of portal pressure 5 , but decreasing hepatic portal-venous perfusion 6 . Although SPSS formation has been assumed as the result of dilatation of preexisting vascular channels, research studies have also implied an active process of neoangiogenesis 7, 8 . SPSS can be visualized and characterized on abdominal imaging 9 . Their presence has been associated with recurrent or persistent HE [10] [11] [12] , but very few small case-control and cohort studies describe the prevalence of SPSS, either using ultrasound or cross-sectional imaging methods [13] [14] [15] [16] . Moreover, identification of SPSS has potential therapeutic implications; in the last years, large SPSS have been assessed as a therapeutic target by embolization, especially in patients with preserved liver function [17] [18] [19] . However, the true prevalence of SPSS in patients with cirrhosis remains unclear and whether the presence and size of SPSS are predictors of complications and mortality has not been systematically evaluated in large cohorts.
The aims of the present study were (i) to determine the prevalence and characteristics of SPSS in cirrhosis and (ii) to assess the impact of SPSS on clinical outcomes and mortality.
PATIENTS AND METHODS
In this multicenter international study, data from cirrhotic patients were retrospectively assessed. Patients were recruited from fourteen centers: five in Spain, two in Germany, one in United Kingdom, Austria, Canada, Switzerland, Italy, Belgium and Denmark. The protocol, conformed to the Declaration of Helsinki, was approved by the ethical review boards of each participating center. All authors had access to the study data and reviewed and approved the final manuscript.
Study cohort and data collection
All cirrhotic patients older than 18 years who underwent a contrast-enhanced abdominal computed tomography (CT) or an abdominal magnetic resonance imaging (MRI) for any reason between 2010 and 2015 were consecutively selected for the study. If available, CT was the imaging technique of choice. The diagnosis of cirrhosis was based on medical history, liver biopsy or unequivocal clinical data with compatible findings on imaging techniques. Exclusion criteria were: presence of hepatocellular carcinoma (HCC) beyond Milan criteria, previous transjugular intrahepatic portosystemic shunt (TIPS) or surgical shunt, any medical condition with expected survival of less than 6 months, presence of neurological or psychiatric disorder preventing a proper HE evaluation and absence of critical information in the medical history.
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Patients were identified in each center through a search that combined reviewing the registry of imaging studies ordered by the Liver Unit, the registry of the Radiological Service and coded diagnoses that included general terms as cirrhosis or liver disease, restricted to years 2010-2015. All information was anonymized, coded and gathered from medical records and clinical databases in every center. A coded database was used for data collection that was centrally processed.
Patients fulfilling inclusion and lacking exclusion criteria had their medical history reviewed. Date of inclusion was considered the date of CT/MRI and defined as baseline. Demographic characteristics, etiology of liver disease, comorbidities, previous complications of cirrhosis, and relevant treatment were recorded. Laboratory and clinical parameters were collected at baseline. Data from esophagogastroduodenal (EGD) endoscopy were analyzed, if available within a 12 month period before or after the CT/MRI. Also, liver stiffness by transient elastography (TE, FibroScan®, Echosens, Paris, France) and hepatic venous pressure gradient (HVPG), were also collected when available in the subgroup of patients with good liver function if the tests had been performed within a 12 month period before or after the imaging. Clinically significant portal hypertension (CSPH) was defined as a HVPG greater than 10 mmHg. Liver function was evaluated at baseline with the model for end-stage liver disease (MELD) and Child-Pugh scores 20, 21 . The degree of disability and dependence in daily activities was assessed through the modified Rankin Scale (mRS) 17, 22 . Follow-up was performed by recording all decompensating events and complications, including overt HE, ascites, gastrointestinal (GI) bleeding due to portal hypertension, hepatorenal syndrome (HRS), spontaneous bacterial peritonitis (SBP), other infections and development of HCC from the time of inclusion (baseline) until liver transplant, death or last available during the study period (until one year after the inclusion period had finished). HE was characterized by the grade of its worst episode (according to the West-Haven scale 23 ) and its clinical course, defined as episodic (isolated episodes), recurrent (in case of bouts that occur with a time interval of 6 months or less) or persistent (if the pattern of behavioral alterations was permanent) 10, 11 .
Radiological data and definitions
Abdominal CT and MRI were reviewed by a radiologist with expertise in hepatic disease at each center (in 13 of the 14 centers) or by an hepatologist trained by a radiologist (in one center) and instructed to search for the presence of SPSS. A predefined protocol for imaging analysis was not used. SPSS were considered as spontaneous communications between the portal venous system or splanchnic veins and the systemic venous system, excluding gastroesophageal varices. SPSS were classified in large or small size according to its maximum diameter, with a cut-off at 8 mm. This cut-off was chosen since it was the smallest size of a symptomatic shunt embolized reported in the literature 24 . According to the diameter and presence of SPSS, patients were classified into three groups: large SPSS (L-SPSS), small SPSS (S-SPSS) or without SPSS (W-SPSS). In addition to the SPSS details, other radiological information was collected (presence of portal or splanchnic vein thrombosis, spleen size, ascites). Splenomegaly was defined as a longitudinal diameter larger than 13 cm. The result of a Doppler-ultrasound that had been performed closest to the CT/MRI was also collected, recording venous portal flow direction and velocity, if available.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Outcomes
The main outcomes were the incidence of complications of cirrhosis and mortality according to the presence of SPSS. Secondary measurements were the prevalence of SPSS in cirrhotic patients and the radiological characteristics of SPSS.
Statistical analysis
The statistical software SPSS (version 22.0; SPSS Inc., Chicago, IL) was used for all analysis. Categorical variables were compared using the Pearson's X2 test, quantitative variables were compared among groups using the analysis of variance (ANOVA) and Student's t test was used for compare unpaired data between two groups. Results are presented in percentage, as mean and standard deviation (SD) or as median and interquartile range (IQR). All reported p values are twotailed. P values ≤0.05 were considered as statistically significant. For statistical analysis of survival, transplant-free survival was considered. Survival curves were performed with the Kaplan-Meier method and the log-rank test was used to assess differences between groups. A multivariate analysis was performed to estimate the adjusted effect of SPSS using the forward selection method. Variables were included if p value was ≤0.1 at univariate analysis. Well-known confounding factors (age, gender, liver function) were also included in the models regardless of p value at univariate analysis. Liver function was assessed separately as MELD and Child-Pugh score, in order to avoid collinearity. Disease duration was not included to avoid overfitting and collinearity with age. The selected potential confounders were assessed in a Cox proportional hazards model. After the global analysis, the different outcomes were stratified by MELD score to analyze the effect of liver function. Patients were divided and classified in three MELD subgroups (according to tertiles, using percentiles 33 and 66 as cut-offs). Child-Pugh stages A, B and C were also used for the same purpose, but MELD was prioritized over Child-Pugh for being more objective and not including portal hypertensive parameters such as ascites and HE (both outcome parameters).
RESULTS
From a total of 2978 patients who were assessed for eligibility (Figure 1) , 1729 patients were included in the study and 1249 patients were excluded. L-SPSS were identified in 488 patients (28%), S-SPSS in 548 patients (32%) and no shunt was identified in 693 patients (W-SPSS: 40%). Distribution of SPSS across different centers is shown in Suppl. Table 1 
Baseline characteristics and previous complications
Baseline characteristics and previous decompensating events of the study cohort are shown in Table 1 . Alcohol was the main etiology in L-SPSS group, while HCV infection was mostly found in W-SPSS group. Among the two most predominant types of L-SPSS ( Table 2) , alcoholic cirrhosis was mainly associated with paraumbilical shunts (53% of patients with paraumbilical shunts had alcoholic cirrhosis), and less with splenorenal shunts (37%). Patients had no differences in the distribution of comorbidities. Statistical differences in liver function were found: patients with L-
SPSS had higher MELD scores and belonged more often to Child-Pugh B and C classes (Suppl. Figure 1 ) than patients with S-SPSS, and both had a worse liver function compared to the W-SPSS group. Biochemical parameters also showed higher serum levels of bilirubin and INR and lower levels of albumin, hemoglobin and platelet count in L-SPSS, followed by S-SPSS and W-SPSS. Patients from the L-SPSS group had experienced more complications of cirrhosis and were treated more frequently with liver-related drugs. Data from 1590 patients submitted to an EGD endoscopy were available, but only those performed 12 months before or after the CT were analyzed (981 patients). Patients with SPSS had a higher prevalence of esophageal varices, gastric varices and portal-hypertensive gastropathy, but without differences in terms of variceal size.
Radiological characteristics
Among the 1729 patients studied, 1630 contrast-enhanced abdominal CT and 99 abdominal MRI were examined. The main reason for performing the imaging study was the assessment of a hepatic nodule found by ultrasound (29%), followed by the characterization of the underlying liver disease (28%). The two techniques allowed identifying L-SPSS in a similar proportion (28% with CT, 34% with MRI, p=0.16).
The most common type of L-SPSS identified was splenorenal (46%), followed by paraumbilical (27%) ( Table 2 ). The mean diameter was 14 mm, with a minimum of 8 mm (according to the study definition) and a maximum of 50 mm. More than one L-SPSS was identified in 9% of the L-SPSS group. More than a third of patients (37%) with L-SPSS also had detectable small collaterals, with paraumbilical veins being the most common type described (48%). In the S-SPSS group, the type most frequently described was paraumbilical (54%), followed by splenorenal shunts (18%).
The mean portal diameter was 14.3 mm (14.5 mm (SD 3.8 mm) in L-SPSS, 15.0 mm (SD 2.8 mm) in S-SPSS and 13.6 mm (SD 2.7 mm) in W-SPSS, p<0.001), suggesting a higher portal pressure in the SPSS groups. Portal vein thrombosis was found in 10% of the total sample (partial 5%, complete 2% and cavernous transformation 3%). The distribution of portal vein thrombosis in relation with SPSS was 18% in L-SPSS (partial 7%, complete 4% and cavernous transformation 7%), 10% in S-SPSS (partial 6%, complete 2% and cavernous transformation 3%) and 5% in W-SPSS (partial 3%, complete 1% and cavernous transformation 1%) (p<0.001). Moreover, 6% of the total sample had a splanchnic thrombosis (L-SPSS 4%, S-SPSS 1% and W-SPSS 1%; p<0.001).
Splenomegaly was observed in 67% of the total sample (L-SPSS 81%, S-SPSS 71% and W-SPSS 54%, p<0.001). HCC within Milan criteria was found on 16% of the imaging tests: the percentage did not differ significantly in the 3 groups, neither in the size of the larger nodule, nor in the number of nodules.
Data from the closest Doppler-ultrasound were collected in 1082 patients. The median time between study inclusion and ultrasound imaging was 3.1 months (IQR 7.9). Hepatofugal flow was observed more frequently in patients with L-SPSS (5% of the total sample: 13% in L-SPSS group, 3% in S-SPSS group and 2.5% in W-SPSS group; p<0.001). In the group of patients with hepatopetal flow, mean velocity was slightly lower in the L-SPSS group (17.3 cm/s), compared with S-SPSS and W-SPSS (19.0 cm/s in both), but without statistical differences.
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Follow-up: Hepatic encephalopathy
During follow-up, patients with L-SPSS developed episodes of HE more frequently than patients with S-SPSS and these than W-SPSS (48%, 34% and 20% respectively; p<0.001) ( Table 3) . A chronic course (both persistent and recurrent HE) was identified more often in the L-SPSS group, followed by S-SPSS and W-SPSS (25% for L-SPSS, 15% for S-SPSS and 7% for W-SPSS; p<0.001). However, differences in severity according to West-Haven criteria were not observed.
Follow-up: Other complications of cirrhosis
Patients with shunts (L-SPSS and S-SPSS) experienced portal hypertension-related GI bleeding, ascites, SBP and HRS more commonly during follow-up than patients of the W-SPSS group ( Table  3) . There was no difference in the frequency of these complications between L-SPSS and S-SPSS groups. Overall 6% of patients required a TIPS during follow-up; W-SPSS patients needed a TIPS in a significantly lower rate than both SPSS groups. The percentage of non-SBP infections and the development of HCC (relapse and new diagnosis) did not differ among groups.
Decompensating events according to the type of collateral
According to the type of L-SPSS found, there were no differences in the kind of decompensating event that patients presented (Suppl. Table 2 ). Gastric varices were more often found in patients with gastrorenal shunts, an association that has been previously reported 25 . Nevertheless, no differences were observed in the prevalence and size of esophageal varices across the different types of SPSS.
Performance status and survival
With regards to performance status, a higher proportion of patients from W-SPSS group were autonomous (mRS 0-1) compared to S-SPSS and L-SPSS (88%, 80% and 75%, respectively), while the rate of patients with limited activities (mRS 2-3: 12%, 19% and 23%) or disability (mRS 4-5: 0%, 1% and 2%) was larger in the L-SPSS group (p<0.001).
Transplant-free survival was significantly higher in the W-SPSS group, compared to S-SPSS and L-SPSS group (log-rank test p<0.001). At the end of the follow-up period, 416 patients of the 1729 included had died (L-SPSS 38%, S-SPSS 29% and W-SPSS 32%) and 239 had been transplanted (L-SPSS 36%, S-SPSS 34% and W-SPSS 30%). The Hazard Ratio (HR) for death/liver transplant was 1.36 (95% confidence interval [CI], 1.13-1.64) for S-SPSS and 1.60 (95% CI, 1.33-1.93) for L-SPSS (Figure 2) . The most common causes of death recorded were liver failure (33%), infections (22%) and HCC (14%), without statistical differences among groups.
The univariate analysis of baseline characteristics between patients alive at the end of follow-up and patients dead/transplanted is shown in Suppl. Table 3 . Variables significantly associated with the outcome and entered into the multivariate model were age, gender, diabetes mellitus, platelet count, MELD score, HCC and presence of SPSS. Suppl. Table 4 represents the results of the multivariate analysis for mortality/liver transplant: age, MELD score, a diagnosis of HCC and presence of SPSS were independent predictors of transplant-free survival.
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Analysis by liver function
Analysis of the data was performed stratifying patients by MELD strata (tertiles), in order to avoid the possible effect that the distribution of liver function could have had on the results. Patients were divided in three similar groups according to their MELD score, using percentiles 33 and 66 as the cut-off points: the first group included scores from 6 to 9; the second group, from 10 to 13 and the third group, from 14 onwards. Although MELD score seems more suitable to stratify patients according to liver function for outcome analyses including HE, we also performed the analysis stratifying by Child-Pugh stage.
The independent effect of etiology in the prevalence of SPSS (higher prevalence of alcoholic cirrhosis) was lost in the two higher MELD groups, however it was maintained in the MELD 6-9 group. HE remained more frequent in patients with L-SPSS, independently on their liver function strata, as shown in Table 4 . Similar results were obtained stratifying by Child-Pugh stage (Suppl. Table 5 ). Among patients with HE, a recurrent or persistent course was identified with more frequency in SPSS patients with worse liver function (MELD score ≥14).
Regarding other complications, the presence of SPSS was associated with a higher risk of portal hypertension-related GI bleeding and a high rate of ascites in patients with preserved liver function (MELD score 6-9) (Table 4) or Child-Pugh A patients (data not shown). Related to this, a more extensive analysis of markers of portal hypertension was performed with the available information in the group of patients with Child-Pugh A (Supp. Table 6 ). As seen, SPSS patients presented more indicators of portal hypertension, including HVPG values and presence of CSPH, than W-SPSS patients. On the other hand, presence of SPSS had an effect on outcomes independent of presence of CSPH. Patients with SPSS and CSPH significantly developed more decompensating events (34 of 50 patients, 68%) than patients without SPSS and with CSPH (12 of 27 patients, 44%) (p= 0.047, OR 2.66, CI 1.01-6.97).
Performance status results showed a higher percentage of limitation or disability in L-SPSS patients, compared to S-SPSS and W-SPSS, in the subgroup of patients with good liver function (MELD 6-9) (Suppl. table 7).
Transplant-free survival in the two subgroups of patients with MELD ≥10 was not significantly different between SPSS patients (L-SPSS+S-SPSS) and W-SPSS patients (Figure 3B-C) . However, in the subgroup with the lowest MELD, differences were observed (log-rank test p=0.020): HR for death/liver transplant was 1.57 (95% CI, 1.08-2.30) in SPSS (L-SPSS+S-SPSS) with respect to W-SPSS group (Figure 3A) . Individual HR for L-SPSS and S-SPSS are shown in Suppl. 
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DISCUSSION
This is the first study that evaluates a large cohort of patients with cirrhosis to determine whether the presence of SPSS correlates with clinical events during the course of the disease. Our results suggest that SPSS might develop as a consequence of a progressive increase in portal pressure and their presence identifies cirrhotic patients at higher risk for more complications and worse outcomes.
The current study shows, first of all, that SPSS are very frequent in liver cirrhosis. In the present series, 60% of cirrhotic patients had some type of SPSS detected by imaging. Among L-SPSS, the type most often identified was splenorenal, followed by paraumbilical. This is in line with the results of previous small studies performed using ultrasound [26] [27] [28] . Our study allows diagnosing other SPSS that can be identified more easily using cross-sectional imaging, due to the improved sensitivity for visualising deep vessels in comparison to ultrasound. Another interesting finding is that alcoholic cirrhosis is more frequently associated to SPSS than other etiologies, specifically in patients with preserved liver function. This is an unexplained association that was already reported in a study from Taiwan 29 . In our patients, cirrhosis was diagnosed before in HCV patients than in alcoholic patients with respect to time of inclusion in the study. It might be plausible that cirrhosis secondary to chronic viral hepatitis are diagnosed earlier in the course of the disease that cirrhosis secondary to alcoholic liver disease. In the mention report 29 , alcoholic cirrhotic patients presented five times more paraumbilical collaterals detected by ultrasound than patients with viral cirrhosis. In accordance with that, alcoholic cirrhosis was the predominant etiology (53%) in patients with paraumbilical L-SPSS.
Another aspect to highlight is that the presence of SPSS increases considerably as liver function deteriorates; the finding of SPSS was more probable if MELD score was above 10 than with MELD 6-9. Similar data were obtained with Child-Pugh staging. Our interpretation of these results is that increasing portal pressure is the main driving force in SPSS development. These results are in line with a previous small study that involved HVPG measurement and evaluation of collaterals on ultrasound, showing that SPSS were more often observed in patients with HVPG ≥16 mmHg 30 . Regarding HE, the experience with TIPS and surgical shunts has clearly shown that portosystemic shunting plays a key role in HE development. After TIPS placement, the incidence of overt HE increases to 10-50% during the first year 31 , with similar data obtained with surgical shunts 32 . The association of HE and the presence of L-SPSS has been reported in case reports, limited clinical series and few small-sized case-control studies [13] [14] [15] 24, 33 . Riggio, et al. 13 showed that the percentage of L-SPSS was higher among patients with recurrent or persistent HE (71%) with respect to the control group with no HE (14%), but in a limited sample (14 patients per group). The present study clearly confirms the association between HE and SPSS, especially L-SPSS, across all different liver function subgroups. In addition HE shows a more chronic and recurrent course in these patients, affecting quality of life. However, we were unable to demonstrate an association between SPSS and the severity of HE measure by the West-Haven scale. The reason for this is probably explained by the study protocol design, in which only the worst episode of HE was recorded, without considering the total number of grade III/IV per patient.
With regards to the relation between SPSS and other complications of cirrhosis, the available information up to date was scarce and contradictory; the finding of SPSS has been related to M A N U S C R I P T
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13 portal hypertension, but with different conclusions. The case-control study performed by Riggio et al. 13 found that patients with chronic HE and L-SPSS had less ascites, esophageal varices and portal-hypertensive gastropathy than patients without SPSS, suggesting than L-SPSS could have a protective role. Nevertheless, in former studies [14] [15] [16] , presence of SPSS was not associated with lower risk of bleeding or ascites as compared to controls. Berzigotti et al. 27 evaluated the relationship between SPSS detected by ultrasound and the presence of esophageal varices, concluding that the development of new SPSS was associated with a higher rate of varices formation and growth. In the present study, SPSS were associated with more portal hypertensionrelated signs and complications, such as splenomegaly, gastroesophageal varices, GI bleeding, ascites, HRS and SBP. This association was especially relevant in cirrhotic patients with preserved liver function (MELD 6-9 or Child-Pugh A), who showed higher HVPG values and more CSPH, and exhibited significantly more portal hypertension related complications (bleeding and ascites) during follow-up than patients without SPSS. In addition, the presence of SPSS in patients with CSPH was associated to higher rate of complications compared to W-SPSS patients with CSPH. Thus, the finding of SPSS in patients with good liver function probably identifies a subgroup of patients with more advanced portal hypertension, who are more likely to develop complications and might have a worse prognosis. It is worth to mention that regarding the risk of complications related to portal hypertension, patients with L-SPSS and S-SPSS seem to behave similarly, with a similar incidence of complications during follow-up.
Even more important, however, is the association between SPSS and decreased transplant-free survival. Although there is a clear relationship between the presence of SPSS and liver function, SPSS were independently associated to mortality/transplant on multivariate analysis. Moreover, it is precisely in the subset of patients with low MELD (6-9) or Child-Pugh A, in which this association with lower survival was more remarkable. Therefore in the subgroup of cirrhotic patients with preserved liver function, the presence of SPSS is a prognostic marker for a higher risk of complications and lower survival. These patients would probably benefit from a closer surveillance and more intensive therapy.
Few reports have been published about the characteristics of collaterals in cirrhosis. Some of them have suggested an association among the type of SPSS and the predominant kind of complication 25 . Anatomically, splenorenal and gastrorenal shunts have been linked more frequently with gastro-esophageal varices, and an increased risk of bleeding 28 . Paraumbilical shunts, that drain into the external iliac vein, without feeding the esophageal venous area, have been associated with less variceal bleeding and more ascites 34, 35 , while their relation with HE remained questionable 36 . These results were not confirmed in other series 37 . In this large cohort, an association between with the type of complication and SPSS was not observed, except for a higher percentage of gastric varices in gastrorenal shunts, an association already reported 25, 27 . As explained, HE was more frequent in L-SPSS, indicating that the diameter of the shunt plays a role in this complication, but portal-hypertensive complications results were similar in patients with L-SPSS and S-SPSS, suggesting that both are indicators of severe portal hypertension.
Our results have the limitations of a retrospective study, mainly originated from data retrieval by reviewing medical charts. Some data, such as HVPG, TE, ultrasound or endoscopy results, were not available in all patients. In addition, the lack of a predefined systematic protocol for imaging analysis might explain differences of SPSS prevalence among centers. Finally, imaging tests were M A N U S C R I P T
14 only evaluated at one time point and a prospective longitudinal study should be performed to analyse data about radiological improvement or deterioration according to the disease course.
There are several strengths of the study. Participants involved were all from tertiary-care university hospitals, with a protocolized management of cirrhotic patients. This is the largest cohort ever reported about SPSS with data provided from 14 hospitals, from 9 different countries, allowing the generalization of the results. The review of the imaging tests by expert radiologists is also an added value. Finally, the stratified analysis by MELD score and Child-Pugh class is an important element of the study eliminating the confounding factor of liver function in the relationship between SPSS and clinical outcomes.
In conclusion, SPSS are frequent in patients with cirrhosis, with splenorenal collaterals found to be the most common type of L-SPSS. The prevalence of SPSS increases as liver function deteriorates, probably as a consequence of worsening portal hypertension, but without achieving an effective protection against its complications. Recurrent or persistent HE is more frequent in patients with SPSS, independently of liver function. Patients with good liver function and SPSS develop more portal hypertension-related complications (GI bleeding and ascites) and have a lower transplantfree survival. In patients with preserved liver function, SPSS therefore identifies patients with a higher risk of worse outcomes, and should be considered an important imaging biomarker in cirrhosis. 59 (12) 58 (12) 
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